Safety and efficacy of plerixafor dose escalation for the mobilization of CD34\\r ⁺\\r hematopoietic progenitor cells in patients with sickle cell disease: interim results

ID：am030003M0034563623jgep18📫 -页

$Safety and efficacy of plerixafor dose escalation for the mobilization of CD34\\r <sup>+</sup>\\r hematopoietic progenitor cells in patients with sickle cell disease: interim results$

⚠ 举报⚠ 版权申诉

内容摘要

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34\\r ⁺\\r hematopoietic progenitor cells in patients with sickle cell disease: interim results

海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方，仅供网友学习交流，请勿商用!